Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › KRas G12C inhibitors

KRas G12C inhibitors

US Patent 11548888 · Granted Jan 10, 2023

Estimated economic value: $49,602,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of palbociclib and adagrasib for lung cancer2025
Naphthyridine derivatives as PRC2 inhibitors2025
Naphthyridine derivatives as PRC2 inhibitors2025
Tetrahydropyridopyrimidine pan-KRas inhibitors2025
Tetrahydropyridopyrimidine pan-KRas inhibitors2025
Azaquinazoline pan-KRas inhibitors2025
Azaquinazoline pan-KRas inhibitors2025
Combination therapies2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Compounds for FGFR inhibition2025